Your shopping cart is currently empty

Eclazolast (RHC 2871) is a lipophilic anti-allergic compound that inhibits mediator release in a mast cell model.Eclazolast inhibits extracellular secretion by affecting only the direct processes associated with Fc(epsilon)RI in the cell.The effect of Eclazolast is highly dependent on the concentration of antigen that triggers the cell.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $120 | In Stock | In Stock | |
| 5 mg | $290 | In Stock | In Stock | |
| 10 mg | $440 | In Stock | In Stock | |
| 25 mg | $728 | In Stock | In Stock | |
| 50 mg | $987 | In Stock | In Stock | |
| 100 mg | $1,390 | In Stock | In Stock | |
| 500 mg | $2,770 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $276 | In Stock | In Stock |
| Description | Eclazolast (RHC 2871) is a lipophilic anti-allergic compound that inhibits mediator release in a mast cell model.Eclazolast inhibits extracellular secretion by affecting only the direct processes associated with Fc(epsilon)RI in the cell.The effect of Eclazolast is highly dependent on the concentration of antigen that triggers the cell. |
| Targets&IC50 | Rat:12 mg/kg(ED50), AIR:800 microM |
| In vitro | Eclazolast down-regulates IP3 levels. In contrast to lipophilic drugs, eclazolast does not affect artificial bilayers and erythrocyte membranes, and there is no effect on thapsigargin-induced Ca2+ influx. The effect of eclazolast was highly dependent on the antigen concentration with which the cells were triggered.[1] |
| In vivo | REV 2871 (CHBZ) was shown to be potent and orally effective inhibitors of passive cutaneous anaphylaxis (PCA) in the rat (ED50 = 12 mg/kg). In the guinea pig lung slice model, CHBZ inhibited AIR (IC50 = 800 microM).[2] |
| Synonyms | RHC-2871, RHC2871, RHC 2871, REV2871, REV 2871 |
| Molecular Weight | 269.68 |
| Formula | C12H12ClNO4 |
| Cas No. | 80263-73-6 |
| Smiles | C(OCCOCC)(=O)C=1OC=2C(N1)=CC(Cl)=CC2 |
| Relative Density. | 1.313g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 27.5 mg/mL (101.97 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.